Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Cell Mol Neurobiol ; 37(7): 1311-1318, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28124209

ABSTRACT

Amyloid-ß protein (Aß) neurotoxicity occurs along with the reorganization of the actin-cytoskeleton through the activation of the Rho GTPase pathway. In addition to the classical mode of action of the non-steroidal anti-inflammatory drugs (NSAIDs), indomethacin, and ibuprofen have Rho-inhibiting effects. In order to evaluate the role of the Rho GTPase pathway on Aß-induced neuronal death and on neuronal morphological modifications in the actin cytoskeleton, we explored the role of NSAIDS in human-differentiated neuroblastoma cells exposed to Aß. We found that Aß induced neurite retraction and promoted the formation of different actin-dependent structures such as stress fibers, filopodia, lamellipodia, and ruffles. In the presence of Aß, both NSAIDs prevented neurite collapse and formation of stress fibers without affecting the formation of filopodia and lamellipodia. Similar results were obtained when the downstream effector, Rho kinase inhibitor Y27632, was applied in the presence of Aß. These results demonstrate the potential benefits of the Rho-inhibiting NSAIDs in reducing Aß-induced effects on neuronal structural alterations.


Subject(s)
Actins/metabolism , Amyloid beta-Peptides/toxicity , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cytoskeleton/enzymology , Peptide Fragments/toxicity , Signal Transduction/physiology , rho-Associated Kinases/physiology , Cell Line, Tumor , Cytoskeleton/drug effects , Cytoskeleton/pathology , Enzyme Inhibitors/pharmacology , Humans , Signal Transduction/drug effects , rho-Associated Kinases/antagonists & inhibitors
2.
Neurobiol Aging ; 35(3): 472-81, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24112789

ABSTRACT

The mechanism by which amyloid-ß (Aß) produces brain dysfunction in patients with Alzheimer's disease is largely unknown. According to previous studies, Aß might share perforating properties with gramicidin, a well-accepted membrane-disrupting peptide. Therefore, we hypothesize that the key steps leading to synaptotoxicity by Aß and gramicidin involve peptide aggregation, pore formation, and calcium dysregulation. Here, we show that Aß and gramicidin form aggregates enriched in ß-sheet structures using electron microscopy, and Thioflavin and Congo Red staining techniques. Also, we found that Aß and gramicidin display fairly similar actions in hippocampal cell membranes, i.e. inducing Ca(2+) entry and synaptoxicity characterized by the loss of synaptic proteins and a decrease in neuronal viability. These effects were not observed in a Ca(2+) free solution, indicating that both Aß and gramicidin induce neurotoxicity by a Ca(2+)-dependent mechanism. Using combined perforated patch clamp and imaging recordings, we found that only Aß produced a perforation that progressed from a small (Cl(-)-selective pore) to a larger perforation that allowed the entry of fluorescent molecules. Therefore, based on these results, we propose that the perforation at the plasma membrane by Aß is a dynamic process that is critical in producing neurotoxicity similar to that found in the brains of AD patients.


Subject(s)
Alzheimer Disease/etiology , Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/toxicity , Cell Membrane/drug effects , Cell Membrane/metabolism , Gramicidin/metabolism , Gramicidin/toxicity , Hippocampus/cytology , Neurons/cytology , Animals , Calcium/metabolism , Calcium Signaling/physiology , Cell Membrane/pathology , Cell Membrane/ultrastructure , HEK293 Cells , Hippocampus/metabolism , Humans , Membrane Potentials/drug effects , Microscopy, Electron, Scanning Transmission , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL